King Hussein Cancer Center
King Hussein Cancer Center
Amman, Jordan7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Follow-up in Gynecological Cancer Survivors | female reproductive organ cancer | Active, not recruiting | Not stated | 2026-10-07 | NCT03515993 | |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-09-21 | NCT05894239 | |
| HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC) | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Not applicable | 2026-09-03 | NCT07801235 | |
| CT-Guided vs Conventional DLT Sizing in Thoracic Surgery | One-lung Ventilation; Thoracic Surgery | Recruiting | Not applicable | 2026-08-07 | NCT07575763 | |
| MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Not applicable | 2026-08-05 | NCT07371403 | |
| Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, central nervous system cancer, central nervous system neoplasm, epithelial neoplasm, glioma, malignant glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-05-13 | NCT06528691 | |
| Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL | Non-Hodgkin Lymphoma Refractory/ Relapsed | Recruiting | Phase 2 | 2025-12-09 | NCT07271121 |